10mg Trilotab Chewable Tablets for Dogs - Pack of 30
953581
Trilotab 10mg Chewable Tablets for Dogs: Managing Canine Cushing’s Syndrome
10mg Trilotab contains trilostane, an active substance that inhibits the enzyme 3β-hydroxysteroid dehydrogenase. This inhibition reduces cortisol synthesis in the adrenal glands, thereby decreasing excessive cortisol levels in dogs with Cushing’s syndrome.
Administered orally, 10mg Trilotab is designed as a chewable, flavoured tablet to facilitate ease of administration. The tablet features a cross-shaped break line, allowing it to be divided into two or four equal parts to achieve precise dosing tailored to the dog's weight and specific needs.
VETERINARY PRESCRIPTION REQUIRED
Product Features
- Pack Size: - Box of 30 Tablets
- Target Animal: - Dog (Canine)
- Pet Prescription Required?: - Yes
More Information
Description
Cushing’s syndrome, or hyperadrenocorticism, is a prevalent endocrine disorder in dogs, particularly affecting those in middle to older age. It arises from prolonged exposure to elevated cortisol levels, a hormone produced by the adrenal glands. This condition can lead to various health issues, including increased thirst and urination, excessive appetite, abdominal enlargement, hair loss, and muscle weakness.
Understanding Cushing’s Syndrome in Dogs
Cushing’s syndrome manifests in two primary forms:
-
Pituitary-Dependent Hyperadrenocorticism (PDH): This is the most common form, accounting for approximately 85% of cases. It results from a benign tumour in the pituitary gland at the brain's base, leading to excessive production of adrenocorticotropic hormone (ACTH). Elevated ACTH levels stimulate the adrenal glands to overproduce cortisol.
-
Adrenal-Dependent Hyperadrenocorticism (ADH): This form is less common and occurs due to a tumour in one or both adrenal glands, causing increased cortisol production.
Common clinical signs of Cushing’s syndrome include:
- Increased thirst and urination
- Increased appetite
- Abdominal distension, often referred to as a "pot-bellied" appearance
- Hair loss, particularly on the body’s trunk
- Thinning skin
- Muscle weakness and lethargy
- Panting
- Recurrent skin infections
These symptoms develop gradually and may be mistaken for normal ageing changes. Therefore, a thorough veterinary evaluation is essential for accurate diagnosis and management.
You may also like
Kaminox - Potassium & Amino Supplement For cats/dogs - 60ml
Kaminox for Cats and Dogs
60ml Kaminox is a liquid potassium supplement designed to support cats and dogs with low potassium levels, also known as hypokalaemia. It provides essential potassium along with additional vitamins and amino acids that contribute to overall health and wellbeing. Potassium is a vital mineral required for normal muscle function, nerve transmission, and cellular activity. A deficiency can lead to weakness, lethargy, reduced appetite, and, in severe cases, life-threatening complications.
Hypokalaemia is commonly associated with kidney disease, a condition frequently seen in older cats and dogs. The kidneys play a crucial role in maintaining electrolyte balance, including potassium levels. When kidney function declines, potassium loss can occur, leading to muscle weakness and other health issues. Kaminox helps replenish potassium levels and provides additional nutritional support to maintain proper organ function.
Vetoryl 10mg Capsules - Box of 30
10mg Vetoryl Capsules are used in the treatment of Cushing's syndrome in dogs. Vetoryl may be used for treatment of both pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs. VET PRESCRIPTION REQUIRED
30mg Trilotab Chewable Tablets for Dogs - Pack of 30
Trilotab 30mg Chewable Tablets for Dogs: Managing Canine Cushing’s Syndrome
30mg Trilotab contains trilostane, an active substance that inhibits the enzyme 3β-hydroxysteroid dehydrogenase. This inhibition reduces cortisol synthesis in the adrenal glands, thereby decreasing excessive cortisol levels in dogs with Cushing’s syndrome.
Administered orally, 30mg Trilotab is designed as a chewable, flavoured tablet to facilitate ease of administration. The tablet features a cross-shaped break line, allowing it to be divided into two or four equal parts to achieve precise dosing tailored to the dog's weight and specific needs.
VETERINARY PRESCRIPTION REQUIRED
60mg Trilotab Chewable Tablets for Dogs - Pack of 30
Trilotab 60mg Chewable Tablets for Dogs: Managing Canine Cushing’s Syndrome
60mg Trilotab contains trilostane, an active substance that inhibits the enzyme 3β-hydroxysteroid dehydrogenase. This inhibition reduces cortisol synthesis in the adrenal glands, thereby decreasing excessive cortisol levels in dogs with Cushing’s syndrome.
Administered orally, 60mg Trilotab is designed as a chewable, flavoured tablet to facilitate ease of administration. The tablet features a cross-shaped break line, allowing it to be divided into two or four equal parts to achieve precise dosing tailored to the dog's weight and specific needs.
VETERINARY PRESCRIPTION REQUIRED
